Clinical Trials Browser

Phase 2 × INDUSTRY × pexidartinib × Clear all

NCT04703322 2026-03-04

A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan

Phase 2 Active not recruiting

9 enrolled 10 charts

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

NCT01217229 2020-06-30

Safety and Efficacy Study of PLX3397 in Adults With Relapsed or Refractory Hodgkin Lymphoma

Phase 2 Completed

20 enrolled 7 charts

Hodgkin Disease

NCT01499043 2020-03-04

Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)

Phase 2 Terminated

6 enrolled 6 charts

Prostatic Neoplasms

NCT01349036 2020-03-03

A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma

Phase 2 Terminated

38 enrolled 13 charts

Brain Neoplasms, Glioblastoma